Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Wamhoff

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
FEBS Letters|February 16, 2007
RNA interference targeting alpha8 integrin attenuates smooth muscle cell growthRamin Zargham, Brian R Wamhoff, Gaétan Thibault
Plos One|November 3, 2011
Chromatin immunoprecipitation (ChIP): revisiting the efficacy of sample preparation, sonication, quantification of sheared DNA, and analysis via PCRPamela D Schoppee Bortz, Brian R Wamhoff
Expert Opinion on Drug Metabolism & Toxicology|May 29, 2012
Organotypic systems in drug metabolism and toxicity: challenges and opportunitiesAjit Dash, Brett R Blackman, Brian R Wamhoff
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 10, 2006
Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swineCarol A Witczak, Brian R Wamhoff, Michael Sturek
Comparative Medicine|March 11, 2003
Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swineChristine R Otis, Brian R Wamhoff, Michael Sturek
Physiological Reviews|July 23, 2004
Molecular regulation of vascular smooth muscle cell differentiation in development and diseaseGary K Owens, Meena S Kumar, Brian R Wamhoff
Circulation Research|April 15, 2006
Excitation-transcription coupling in arterial smooth muscleBrian R Wamhoff, Douglas K Bowles, Gary K Owens
The Journal of Clinical Investigation|May 5, 2004
Lost in transdifferentiationMark H Hoofnagle, Brian R Wamhoff, Gary K Owens
American Journal of Physiology. Cell Physiology|October 15, 2011
Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5)Julia A Halterman, H Moo Kwon, Brian R Wamhoff
Expert Opinion on Drug Discovery|December 1, 2017
Non-alcoholic fatty liver disease (NAFLD) models in drug discoveryBanumathi K Cole, Ryan E Feaver, Brian R Wamhoff, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
FEBS Letters|February 16, 2007
RNA interference targeting alpha8 integrin attenuates smooth muscle cell growthRamin Zargham, Brian R Wamhoff, Gaétan Thibault
Plos One|November 3, 2011
Chromatin immunoprecipitation (ChIP): revisiting the efficacy of sample preparation, sonication, quantification of sheared DNA, and analysis via PCRPamela D Schoppee Bortz, Brian R Wamhoff
Expert Opinion on Drug Metabolism & Toxicology|May 29, 2012
Organotypic systems in drug metabolism and toxicity: challenges and opportunitiesAjit Dash, Brett R Blackman, Brian R Wamhoff
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 10, 2006
Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swineCarol A Witczak, Brian R Wamhoff, Michael Sturek
Comparative Medicine|March 11, 2003
Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swineChristine R Otis, Brian R Wamhoff, Michael Sturek
Physiological Reviews|July 23, 2004
Molecular regulation of vascular smooth muscle cell differentiation in development and diseaseGary K Owens, Meena S Kumar, Brian R Wamhoff
Circulation Research|April 15, 2006
Excitation-transcription coupling in arterial smooth muscleBrian R Wamhoff, Douglas K Bowles, Gary K Owens
The Journal of Clinical Investigation|May 5, 2004
Lost in transdifferentiationMark H Hoofnagle, Brian R Wamhoff, Gary K Owens
American Journal of Physiology. Cell Physiology|October 15, 2011
Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5)Julia A Halterman, H Moo Kwon, Brian R Wamhoff
Expert Opinion on Drug Discovery|December 1, 2017
Non-alcoholic fatty liver disease (NAFLD) models in drug discoveryBanumathi K Cole, Ryan E Feaver, Brian R Wamhoff, et al.
Pageof 7